Retraction
Astragaloside IV inhibits oxidized low‑density lipoprotein‑induced endothelial damage via upregulation of miR‑140‑3p
Paper Information
Record ID:
42146
Author(s):
Journal:
Publication Date:
June 26, 2019
Retraction Date:
January 20, 2023
(2.8 years years ago)
Subjects:
Institutions:
- Department of Lung Disease, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250011, P.R. China
- Department of Endocrinology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250011, P.R. China
- Department of Traditional Chinese Medicine, Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250062, P.R. China
- Personnel Section, Shandong Academy of Occupational Health and Occupational Medicine, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong 250062, P.R. China
- Department of Chinese Internal Medicine, Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250355, P.R. China
- Cangzhou Hospital of Integrated Traditional Chinese Medicine and Western Medicine of Hebei, Cangzhou, Hebei 061899, P.R. China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Spandidos
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Retraction Reasons:
Nature of Retraction:
Retraction
Retraction Notice:
10.3892/ijmm.2023.5220Additional Notes:
see also:https://pubpeer.com/publications/41C7FFE9312E76A8CABB51FA564B04
Citations (11)
11
Total Citations3
Post-Retraction(27.3%)
8
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
2
Within 1 year
0
After 2+ years
389
Days since retraction (latest)
Astragaloside IV Protects against Shear Stress-Induced Glycocalyx Damage and Alleviates Abdominal Aortic Aneurysm by Regulating miR-17-3p/Syndecan-1
Guojian Li, Qionghui Yang, Kaikai Luo et al. (7 authors)
Analytical Cellular Pathology
Open Access
Published: Feb 2024
1 citation
1 citation
389 days after retraction
Could Cyclosiversioside F Serve as a Dietary Supplement to Prevent Obesity and Relevant Disorders?
Siqi Qin, Junren Chen, Kexin Zhong et al. (5 authors)
International Journal of Molecular Sciences
Open Access
Published: Sep 2023
2 citations
2 citations
229 days after retraction
The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
Lin Li, Yuwei Zhang, Yudan Luo et al. (8 authors)
Drug Design Development and Therapy
Open Access
Published: Mar 2023
22 citations
22 citations
40 days after retraction
Medicinal and edible plants in the treatment of dyslipidemia: advances and prospects
Ying Hu, Xingjuan Chen, Mu Hu et al. (7 authors)
Chinese Medicine
Open Access
Published: Sep 2022
34 citations
34 citations
113 days before retraction
Isoflavones from Semen Sojae Preparatum Improve Atherosclerosis and Oxidative Stress by Modulating Nrf2 Signaling Pathway through Estrogen-Like Effects
Jinzhou Guo, Jingxin Ma, Kun Cai et al. (8 authors)
Evidence-based Complementary and Alternative Medicine
Open Access
Published: Apr 2022
9 citations
9 citations
288 days before retraction
Noncoding RNAs and RNA-binding proteins in diabetic wound healing
Xue Li, Ning Li, Bingxin Li et al. (6 authors)
Bioorganic & Medicinal Chemistry Letters
Published: Aug 2021
12 citations
12 citations
515 days before retraction
Differentially Expressed Circular Non-coding RNAs in Atherosclerotic Aortic Vessels and Their Potential Functions in Endothelial Injury
Houwei Li, Xue Liu, Na Sun et al. (11 authors)
Frontiers in Cardiovascular Medicine
Open Access
Published: Jul 2021
13 citations
13 citations
562 days before retraction
Circ_0068087 Silencing Ameliorates Oxidized Low-Density Lipoprotein-Induced Dysfunction in Vascular Endothelial Cells Depending on miR-186-5p-Mediated Regulation of Roundabout Guidance Receptor 1
Shuanghong Li, Tao Huang, Limin Qin et al. (4 authors)
Frontiers in Cardiovascular Medicine
Open Access
Published: May 2021
18 citations
18 citations
604 days before retraction
Astragaloside IV alleviates atherosclerosis through targeting circ_0000231/miR-135a-5p/CLIC4 axis in AS cell model in vitro
Xiao Shao, Zhaozheng Liu, Shanshan Liu et al. (5 authors)
Molecular and Cellular Biochemistry
Published: Jan 2021
28 citations
28 citations
737 days before retraction
Transcriptomic Analysis Reveals the Protection of Astragaloside IV against Diabetic Nephropathy by Modulating Inflammation
Yudi Zhang, Chun-He Tao, Chen Xuan et al. (5 authors)
Oxidative Medicine and Cellular Longevity
Open Access
Published: Aug 2020
46 citations
46 citations
889 days before retraction
Astragaloside IV protects ATDC5 cells from lipopolysaccharide-caused damage through regulating miR-203/MyD88
Dexin Li, Guangcheng Li, Yang Chen et al. (8 authors)
Pharmaceutical Biology
Open Access
Published: Jan 2020
18 citations
18 citations
1115 days before retraction
Quick Stats
Total Citations:
11
Years Since Retraction:
2.8 years
Open Access:
Yes
Last Checked:
Jul 24, 2025